Ferrologix Inc

3:00 PM - 3:15 PM (PDT), Monday, June 13, 2022
Ferrologix is a scalable, closed system with the simplicity of MACS and the precision of FACS. System enables higher purity, viability, throughput and yield with rare cells or small specimens. It can simultaneously separate 2 distinct populations with the precision of FACS, with the cost and simplicity of MACS. This technology offers unique benefits for cellular diagnostics, research, and cellular manufacturing.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2015
Main Therapeutic Focus:
Lead Product in Development:
Ferrologix rare cell isolator
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
COO
Ferrologix, Inc.